Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica

Neurology. 2010 May 4;74(18):1471-3. doi: 10.1212/WNL.0b013e3181dc1af3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal* / adverse effects
  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Humans
  • Immunologic Factors* / adverse effects
  • Immunologic Factors* / therapeutic use
  • Magnetic Resonance Imaging
  • Neuromyelitis Optica / drug therapy*
  • Neuromyelitis Optica / pathology
  • Neurotoxicity Syndromes* / pathology
  • Rituximab
  • Syndrome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab